PRAKASH BHUSHAN KARN: Open Payments
NPI 1245487503 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 20 payments from 10 companies in 2025. Trend: 2023 $1,022 · 2024 $1,042 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
| ABBVIE INC. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Indivior Inc. | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: COBENFY, VRAYLAR, CAPLYTA, SUBLOCADE, UZEDY, INGREZZA, Jornay PM, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
